A total of 63 people experienced deep vein thrombosis with five fatalities. Hundreds of people have been harmed by Xeljanz side effectsīy the end of March 2019, the FDA documented 109 self-reported cases of pulmonary embolism, 14 of which were fatal. You might have a case against the makers of Xeljanz. If you’re experiencing any of the above symptoms, seek immediate medical care and then contact an attorney. If you’ve been taking Xeljanz, Xeljanz XR, or tofacitinib, the following symptoms indicate a possible pulmonary embolism (a blood clot that travels to the lungs) or deep vein thrombosis (DVT): Have you experienced venous thromboembolic events after taking Xeljanz? However, for hundreds of patients this warning came too late. Seven years after the FDA approved Xeljanz, the drug manufacturer (Pfizer) announced the risk and added a warning to the box. The risk of death was also increased in this group compared to the control group and the group of patients taking 10mg doses of Xeljanz per day. The study confirmed a higher rate of pulmonary embolism in patients taking 20mg of Xeljanz per day. The clinical safety trial that began in 2012 confirmed that Xeljanz increases the risk of developing blood clots in the lungs. The FDA required an ongoing safety study back in 2012, but the potential for blood clots as a fatal side effect wasn’t discovered until 2019. Unfortunately for innocent patients, Xeljanz didn’t come with a warning about potential blood clots until seven years after the drug was approved. Xeljanz patients weren’t warned about the blood clot risk Blood clots in both of these locations can be fatal. For example, many patients developed blood clots in the lungs and in veins deep within their legs. Patients who have taken Xeljanz have reported multiple forms of venous thromboembolic events. Lab result abnormalities like liver enzyme elevationsĪll of the side effects listed above have been listed on the label from the start, but the risk of fatal blood clots was not included in the list of side effects.īlood clots are extremely dangerous and can be fatal depending on their size and where they are located. Lymphoma, non-melanoma skin cancer, and other types of cancer The Xeljanz and Xeljanz XR labels warn patients of the following side effects: This makes sense for treating autoimmune diseases, but it comes at the price of dangerous and fatal side effects. This drug is also known as Xeljanz and it works by suppressing immune system function. Since 2012, doctors have been treating autoimmune diseases like rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis with a drug called tofacitinib. Xeljanz Side Effects Are Potentially Fatal
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |